Hudson Canyon Capital Management’s Amgen AMGN Stock Holding History

Hudson Canyon Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.95M	Buy	8,144 +1,007	+14%	+$345K	1.58%	21
2026 Q1	$2.51M	Buy	7,137 +112	+2%	+$39.9K	1.54%	25
2025 Q4	$2.3M	Hold	7,025	–	–	1.34%	32
2025 Q3	$2.08M	Buy	7,025 +525	+8%	+$152K	1.2%	36
2025 Q2	$1.81M	Buy	6,500 +1,300	+25%	+$368K	1.13%	46
2025 Q1	$1.62M	Buy	+5,200	New	+$1.54M	1.14%	47
2021 Q3	–	Sell	-7,375	Closed	-$1.8M	–	59
2021 Q2	$1.8M	Buy	7,375 +426	+6%	+$105K	1.35%	41
2021 Q1	$1.73M	Sell	6,949 -606	-8%	-$145K	1.36%	41
2020 Q4	$1.74M	Buy	+7,555	New	+$1.74M	1.38%	39

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hudson Canyon Capital Management's AMGN Position: Q2 2026 in Review

Hudson Canyon Capital Management increased its Amgen (AMGN) stake by 14% in Q2 2026, buying an estimated $345K and bringing the position to 8,144 shares worth $2.95M. The position accounts for 1.58% of the portfolio, ranked #21.

Hudson Canyon Capital Management first reported a position in AMGN in Q4 2020 and has held it in 9 quarters since. 3,136 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Hudson Canyon Capital Management held 8,144 shares of Amgen worth $2.95M as of Q2 2026.
Hudson Canyon Capital Management bought 1,007 Amgen shares in Q2 2026, an estimated $345K.
Amgen made up 1.58% of Hudson Canyon Capital Management's portfolio in Q2 2026, its #21 holding.
Hudson Canyon Capital Management first reported a position in Amgen in Q4 2020 and has held it in 9 quarters since.
3,136 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hudson Canyon Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.